Ameritas Investment Partners’s Biohaven BHVN Stock Holding History

Ameritas Investment Partners’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$81.4K	Buy	9,621 +2,063	+27%	+$22.6K	﹤0.01%	1810
2025 Q4	$85.3K	Hold	7,558	–	–	﹤0.01%	1789
2025 Q3	$113K	Sell	7,558 -1,427	-16%	-$20.8K	﹤0.01%	1606
2025 Q2	$127K	Hold	8,985	–	–	﹤0.01%	1589
2025 Q1	$216K	Hold	8,985	–	–	0.01%	1220
2024 Q4	$336K	Buy	8,985 +1,378	+18%	+$64.3K	0.01%	1023
2024 Q3	$380K	Buy	7,607 +250	+3%	+$9.73K	0.01%	952
2024 Q2	$255K	Buy	7,357 +534	+8%	+$21.1K	0.01%	1106
2024 Q1	$373K	Sell	6,823 -259	-4%	-$12.8K	0.01%	928
2023 Q4	$303K	Buy	7,082 +1,292	+22%	+$40.2K	0.01%	1025
2023 Q3	$151K	Buy	5,790 +730	+14%	+$15.2K	0.01%	1376
2023 Q2	$121K	Hold	5,060	–	–	﹤0.01%	1470
2023 Q1	$69.1K	Hold	5,060	–	–	﹤0.01%	1772
2022 Q4	$97.2K	Buy	+5,060	New	+$71.5K	﹤0.01%	1622

Other funds holding BHVN

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

RPSM

Royalty Pharma Sub-Manager New York $173M AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameritas Investment Partners's BHVN Position: Q1 2026 in Review

Ameritas Investment Partners increased its Biohaven (BHVN) stake by 27% in Q1 2026, buying an estimated $22.6K and bringing the position to 9,621 shares worth $81.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1810.

Ameritas Investment Partners first reported a position in BHVN in Q4 2022 and has held it in 14 quarters since. The position peaked at $380K in Q3 2024. 275 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

Ameritas Investment Partners held 9,621 shares of Biohaven worth $81.4K as of Q1 2026.
Ameritas Investment Partners bought 2,063 Biohaven shares in Q1 2026, an estimated $22.6K.
Biohaven made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #1810 holding.
Ameritas Investment Partners first reported a position in Biohaven in Q4 2022 and has held it in 14 quarters since.
Ameritas Investment Partners's Biohaven position peaked at $380K in Q3 2024.
275 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.